Publications by authors named "Mark Ritter"

Claim this Profile
N
Neoadjuvant Stereotactic Body Radiation Therapy Plus Elective Nodal Irradiation With Concurrent Capecitabine for Patients With Resectable Pancreatic Cancer: Survival Analysis of a Prospective Phase 1 Trial.
Mustafa M Basree, Jacob S Witt, Nataliya V Uboha, Meghan Lubner, Rebecca Minter, Mark A Ritter

Pract Radiat Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe Late Toxicities (Grade 3-5) With 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy.
Kaili Ranta, Andrzej P Wojcieszynski, Shuang G Zhao, Yingzhou Liu, David F Jarrard, Mark A Ritter

Int J Radiat Oncol Biol Phys· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity and Patient-Reported Quality-of-Life Outcomes After Prostate Stereotactic Body Radiation Therapy With Focal Boost to Magnetic Resonance Imaging-Identified Prostate Cancer Lesions: Results of a Phase 2 Trial.
Brett A Morris, Emma E Holmes, Nicholas J Anger, Gregory Cooley, Jessica M Schuster, Mark A Ritter

Int J Radiat Oncol Biol Phys· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moral Injury Among US Public Health Service First Responders During the COVID-19 Pandemic.
Mark Ritter, Mary Vance, John Iskander

Public Health Rep· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using F-DCFPyL Prostate-Specific Membrane Antigen-Directed Positron Emission Tomography/Magnetic Resonance Imaging to Define Intraprostatic Boosts for Prostate Stereotactic Body Radiation Therapy.
John M Floberg, Shane A Wells, Diane Ojala, R Adam Bayliss, Patrick M Hill, Mark Ritter

Adv Radiat Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer.
Mark A Ritter, Patrick A Kupelian, Daniel G Petereit, Colleen A Lawton, Nick Anger

Pract Radiat Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1 Dose Escalation Study of Neoadjuvant SBRT Plus Elective Nodal Radiation with Concurrent Capecitabine for Resectable Pancreatic Cancer.
Jacob S Witt, Aleksandra Kuczmarska-Haas, Meghan Lubner, Scott B Reeder, Steve Y Cho, Mark A Ritter

Int J Radiat Oncol Biol Phys· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation.
Jacob S Witt, Justin C Jagodinsky, Yifei Liu, Poonam Yadav, Aleksandra Kuczmarska-Haas, Mark A Ritter

Am J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semen AMACR protein as a novel method for detecting prostate cancer.
Tyler Etheridge, Jane Straus, Mark A Ritter, David F Jarrard, Wei Huang

Urol Oncol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?
Angela U Pathmanathan, Nicholas J van As, Linda G W Kerkmeijer, John Christodouleas, Colleen A F Lawton, Mark Ritter

Int J Radiat Oncol Biol Phys· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Obituary and Tribute to John "Jack" Francis Fowler, PhD, DSc (1925-2016).
Paul M Harari, Mark A Ritter, Albert J van der Kogel

Int J Radiat Oncol Biol Phys· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation Dose Escalation in Esophageal Cancer Revisited: A Contemporary Analysis of the National Cancer Data Base, 2004 to 2012.
Jeffrey V Brower, Shuai Chen, Michael F Bassetti, Menggang Yu, Paul M Harari, Mark A Ritter

Int J Radiat Oncol Biol Phys· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer.
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, Constantine A Mantz, Arie P Dosoretz, Mark A Ritter

Radiother Oncol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased tumor response to neoadjuvant therapy among rectal cancer patients taking angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
Zachary S Morris, Sandeep Saha, William J Magnuson, Brett A Morris, Jenna F Borkenhagen, Mark A Ritter

Cancer· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life outcomes from a dose-per-fraction escalation trial of hypofractionation in prostate cancer.
Jeffrey V Brower, Jeffrey D Forman, Patrick A Kupelian, Daniel G Petereit, Vinai Gondi, Mark A Ritter

Radiother Oncol· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On voxel-by-voxel accumulated dose for prostate radiation therapy using deformable image registration.
Jialu Yu, Nicholas Hardcastle, Kyoungkeun Jeong, Edward T Bender, Mark A Ritter

Technol Cancer Res Treat· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential role for androgen-deprivation therapy and pelvic radiation therapy in node-positive postprostatectomy prostate cancer.
David F Jarrard, Michael L Blute, Mark A Ritter

J Clin Oncol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)." Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Department of Radiation Oncology, Centre Hospitalier Universitaire A Michallon, Grenoble, France.: Lancet 2012;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. [Epub 2012 Oct 19].
Mark A Ritter

Urol Oncol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Commentary on "initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer." Aizer AA, Chen MH, Hattangadi J, D'Amico AV. Harvard Radiation Oncology program, Boston, MA.: BJU Int 2013. doi: 10.1111/j.1464-410X.2012.11789.x. [Epub ahead of print].
Mark A Ritter

Urol Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of ATM Sequence Variants in Northern Plains American Indian Cancer Patients.
Daniel G Petereit, L Jennifer Hahn, Shalini Kanekar, Amy Boylan, Søren M Bentzen, Mark Ritter

Front Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.
Bret Verhoven, Yan Yan, Mark Ritter, Li-Yan Khor, Elizabeth Hammond

Int J Radiat Oncol Biol Phys· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of urological procedures in men who died from prostate cancer using a population-based approach.
Kara Babaian, Matthew Truong, Jeremy Cetnar, Deanna S Cross, Fangfang Shi, Mark A Ritter

BJU Int· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aggressive adenocarcinoma of the cervical esophagus: importance of a multidisciplinary approach.
Adedayo Fashoyin, Gregory Hartig, William R Schelman, Mark Ritter, Rashmi Agni

Case Rep Gastrointest Med· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historical prostate cancer screening and treatment outcomes from a single institution.
Deanna S Cross, Mark Ritter, Douglas J Reding

Clin Med Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early hypofractionated salvage radiotherapy for postprostatectomy biochemical recurrence.
Tim J Kruser, David F Jarrard, Andrew K Graf, Sean P Hedican, David R Paolone, Mark A Ritter

Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis